| Literature DB >> 33359043 |
N Innes1, I G Johnson2, W Al-Yaseen2, R Harris3, R Jones4, S Kc5, S McGregor6, M Robertson7, W G Wade8, J E Gallagher5.
Abstract
OBJECTIVES: This review aimed to identify which dental procedures generate droplets and aerosols with subsequent contamination, and for these, characterise their pattern, spread and settle. DATA RESOURCES: Medline(OVID), Embase(OVID), Cochrane Central Register of Controlled Trials, Scopus, Web of Science and LILACS databases were searched for eligible studies from each database's inception to May 2020 (search updated 11/08/20). Studies investigating clinical dental activities that generate aerosol using duplicate independent screening. Data extraction by one reviewer and verified by another. Risk of bias assessed through contamination measurement tool sensitivity assessment. STUDY SELECTION: A total eighty-three studies met the inclusion criteria and covered: ultrasonic scaling (USS, n = 44), highspeed air-rotor (HSAR, n = 31); oral surgery (n = 11), slow-speed handpiece (n = 4); air-water (triple) syringe (n = 4), air-polishing (n = 4), prophylaxis (n = 2) and hand-scaling (n = 2). Although no studies investigated respiratory viruses, those on bacteria, blood-splatter and aerosol showed activities using powered devices produced greatest contamination. Contamination was found for all activities, and at the furthest points studied. The operator's torso, operator's arm and patient's body were especially affected. Heterogeneity precluded inter-study comparisons but intra-study comparisons allowed construction of a proposed hierarchy of procedure contamination risk: higher (USS, HSAR, air-water syringe, air polishing, extractions using motorised handpieces); moderate (slow-speed handpieces, prophylaxis, extractions) and lower (air-water syringe [water only] and hand scaling).Entities:
Keywords: Aerosol generating procedures; Aerosols; COVID-19; Evidence-based dentistry; Infection control; Systematic reviews
Mesh:
Substances:
Year: 2020 PMID: 33359043 PMCID: PMC7834118 DOI: 10.1016/j.jdent.2020.103556
Source DB: PubMed Journal: J Dent ISSN: 0300-5712 Impact factor: 4.379
Fig. 1Outline of the search strategy, adapted for each database.
Description of criteria used to assess the methodology/reporting quality of included studies.
| Red (low quality) | Amber (moderate quality/ no mention) | Green (high quality) | |
|---|---|---|---|
| Was the study industry funded (related to the study materials being investigated)? | Yes, industry funded | Not mentioned | Statement that not industry funded |
| Was there a conflict of interest? | Conflict of interest declared (related to the topic or study materials being investigated) | Not mentioned | Clearly states not industry funded or no conflict of interest statement |
| Relevance to routine clinical dentistry | Low – mannikin or simulation study not involving human participants | Medium – human participant study but involving procedures e.g. closed chambers which are very unlike usual dentistry | High – undertaken in dental operatories with human participants |
| Procedure description | Inadequately described | Adequately described to be able to understand what was done but could not be reproduced and could be reproduced | Described in detail and could be reproduced |
| Equipment used in Procedure | Not mentioned | Mentioned but not adequately described (type of item e.g. air rotor)(but no further detail | Adequately described in detail and could be reproduced |
| Sample size | Not mentioned | Mentioned but not described in enough detail to reproduce | Adequately described in detail and could be reproduced |
| Controls (for microbial studies) | No control measures described | Control measures described for example leaving a plate out for an hour before the procedure | Not applicable |
| Sensitivity of measurement for contamination measure (separate for microbiological, blood and visual for spatter)(Further details found on Table 2) | Low sensitivity | Medium sensitivity | High sensitivity |
| Outcome | Outcome reporting do not meet standard i.e. not expressed or statistical tests were not appropriate, not reported | Outcome reporting partially meets standard | Outcomes clearly stated with appropriate descriptive statistics to express contamination for areas as point estimates and include measures of distribution (e.g. standard deviation, standard error and range) and if statistical tests are used to analyse associations, these are appropriate, and include confidence intervals and the probability levels (p value) |
Sensitivity of measurement for contamination measure (separate for microbiological, blood and visual for spatter).
| Blood agar used? | Incubation environment | Incubation duration (days) | |
|---|---|---|---|
| Measurement of microbial contamination | |||
| Low | The study did not use blood agar as growth media. | Aerobic environment was used. | Incubation time (1–3 days) was unsatisfactory for cultivating a wide range of bacteria with different replication rate. |
| Not stated. | Not stated | Not stated. | |
| Moderate | The study used blood agar as growth media. | Aerobic or anaerobic (in consideration to other parameters). | The study used a moderate incubation time for cultivating a moderate range of bacteria with different replication rate. |
| High | The study used blood agar as growth media. | Anaerobic environment was adopted that allowed. | Incubation time (7 days or more) was satisfactory for cultivating a wide range of bacteria with different replication rate. |
| Measurement of blood contamination | |||
| Low | Visible detection with no other equipment used. | ||
| Moderate | Visible detection with the use of visibility of enhancers (e.g. fluorescent dye). | ||
| High | Sophisticated method used for blood detection such as DNA detection with PCR. | ||
| Measurement of non-microbial and non-blood contamination | |||
| Low | Visible detection with no other equipment used. | ||
| Used test with no consideration of dilution effect of blood in interpretation (false negatives). | |||
| Used test with no consideration of impact of hypochlorite in interpretation of surfaces in dental settings (false positives at higher dilutions which is relevant for surfaces rather than gowns/masks/drapes) | |||
| Moderate | Visible detection with the use of visibility of enhancers (e.g. fluorescent dye). | ||
| High | Direct testing; Kastle–Meyer (KM) reagent using phenolphthalein followed by hydrogen peroxide 3 % Leucomalachite green (LMG) reagent followed by hydrogen peroxide 3 % Luminol MG: neat blood to dilution to 10−3 Gives 100 % positive results (less sensitivity with more dilution but still 54.4% at 10-7) LMG: neat blood to dilution of 10−2 Gives 100 % positive results (less sensitivity with more dilution but still 33.3% at 10-7); and | ||
Fig. 2Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) (Moher et al. 2009) flow chart. A full description of study characteristics can be found in Appendix 4.
Fig. 3Publications by date (n = 81; 2 publications from 2020 were not included).
Main characteristics of the included studies categorised by dental procedure/ instrument use (n = 83). Please note that the numbering in this table refers to the list of references (included studies) in Appendix 3 and are not the same numbering system as found in the main text.
| Procedure category (no of studies) | Procedures investigated (e.g. cavity preparation) and type of investigation (clinical/ laboratory, patient/ mannequin) | Investigated contamination of operator, assistant, patient | Area within dental surgery investigated | Different timepoints sampled (hours, minutes, seconds) | Detection sensitivity scores for outcome methodologies |
|---|---|---|---|---|---|
| 0–30 min29,37,83 | (n=34) | ||||
| Head (n=2)16,83 | 30 min-1 hr29,37,83 | ||||
| Body (n=3)31,70,83 | 1–2 hr29,83 | ||||
| 2–4 hr29 | |||||
| Head/face (n=9)96,95, 20,8,81,59,63,55,3, Body (n=2)8,60 | (n=12)93,8,92,42,48,59,63,90,60,81,94,87 | ||||
| Head/face (n=3)8,81,63, Body (n=1)8 | |||||
| Intra-oral (n=1)20, Head/face (n=1)95, Body (n=4)92, 20, 8, 94 | |||||
| Head/ face/neck (n=4) 4, 38, 40, 98 | |||||
| Implants (clinic) (n= 1) 98 | Arms/ Cuffs/ hands | ||||
| (n= 3) 4, 38, 40 | |||||
| Abdomen/ shoes (n= 3) 4, 38, 4 | |||||
| Nearby operator (n=1) 43 | |||||
| Head/ face/neck (n=2) 4, 98 | |||||
| Arms/ Cuffs/ hands, (n=1) 4 | |||||
| Other body parts (n=1) 4 | |||||
| Nearby assistant (n=1) 43 | |||||
| Head/ face, (n=1)4 | |||||
| Chest (n=2)4, 17, 43 | |||||
| Settle plates at 1ft, 2ft and 3ft from the motor n=147 | |||||
| N/A | Experimental Simulation-Air Samples Human aerosol test chamber89 | During procedure (n=3)89,90,93 | |||
| After procedure (n=1)51: at 2 min, 35 min, 2 hr, 4 hr and 6 hr. | |||||
| Quartz crystal microbalance cascade impactor (QCMCI)95 | |||||
| Clinical (splatter plate) 90,91 | |||||
| 0–1m90,91 | |||||
| 1–2m90,91 | |||||
| Air polishing (clinic) (n=3)18,49,53 | Air sampled 12 inches from patients’ mouth at 50o angle53 | 30 min including procedure of 2 min49,53 | |||
| Head/face (n=3)18,49,53 | |||||
| Mannequin/ typodont simulation (laboratory) (n=1)35 | Air sampled < 1m of operating area35 | During procedure (n=2)18,35 | |||
| Body (n=1)18 | Surface < 1m operating area (n=1)49 | ||||
| Surface > 1 m (n=1)49 | |||||
| Prophy on patient’s head in closed experimental test chamber with side glove ports (clinic) (n=1)89 | N/A | Air sampling of the closed chamber around the patient’s head89 | During the procedure (10–120 sec) with 4 min clearance period of quiet breathing before and after89 | ||
| Prophy (clinic) (n=1)90 | Air sampled 3 ft from floor and 1 ft from patients’ mouth (in front) to the sides and end of the surgery90 | During procedure (30 sec)90 | |||
| Hand scaling patient head in closed test chamber with side glove ports (clinic) (n=1)89 | N/A | Air sampling of the closed chamber around the patient’s head89 | During procedure (10–120 sec) with 4 mins clearance period of quiet breathing before and afterwards89 | ||
| Mannequin/typodont simulation (laboratory) (n=1)34 | Air sampled around mouth distance not specified34 | During procedure (2 sec)34 |
Unique study identification numbers.
Dos Santos 201418, Harrel 199935, Logothetis 199549, Muzzin 199953.
m = metre(s); ft – foot/feet; in = inch(es); cm = centimetre(s); hr = hour(s); min = minute(s); sec = second(s).
Balcos 20195, Barnes 19986, Bentley 19948, Choi 20189, Chuang 201410, Devker 201216, Feres 201021, Fine 199222, Fine 1993 a23, Fine 1993b24, Graetz 201425, Grenier 199529, Gupta 201431, Hallier 201032, Harrel 199834, Harrel 199633, Holloman 201537, Jawade 201641, Kaur 201444, King 199745, Labaf 201148, Miller 197190, Mohan 201652, Narayana 201654, Nejatidanesh 201355, Prospero 200359, Purohit 200960, Ramesh 201561, Rao 201562, Reddy 201264, Retamal-Valdes 201765, Rivera-Hidalho 199966, Sadun 202069, Saini 201570, Sawhney 201571, Serban 201372, Sethi 201973, Shetty 201374, Singh 201676, Swaminathan 201478, Timmerman 200480, Veena 201583, Watanabe 201385, Yamada 201187.
Al-Amad 20173, Belting 196393, Bentley 19948, Cochrane 198992, Dahlke 201213, Day 200815, Earnest20, Greco 200828, Grenier 199529, Grundy 196730, Hallier 201032, Hausler 196636, Junevičius 200542, Labaf 201148, Larato 196691, Manarte-Monteiro 201350, Micik 196989, Miller 197190, Miller 199551, Neiatidanesh 201355, Oliveira 201856, Prospero 200359, Purohit 200960, Rautemaa 200663, Samaranayake 198988, Stevens 196396, Tag El-Din 199794, Toroğlu 200181, Toroğlu 20038, Travaglini95, Yamada 201187.
Al-Eid 20184, Divya 201917, Hallier 201032, Ishiharma 200838, Ishiharma 200939, Janani 201840, Jimson 201543, Kobza 201846, Wada 201084, Yamada 201187, Aguilar-Duran 202098.
Agostinho 20042, Dawson 201614, Day 200815, Ireland 200397, Kritivasan 201947.
Belting 196393,, Micik 196989, Miller 197190, Miller 199551.
Micik 196989, Miller 19719.
Harrel 199834, Micik 196989.
Fig. 4Network diagram illustrating where studies included comparison between different procedures within them. (See also Appendix 5). The nodes represent the eight procedures and the lines between them show where a study compares them. The number of studies is shown by ‘n=’ and also the relative thickness of the lines. Where a node has no linkages, there are no studies comparing it with another procedure.
Fig. 5Proposed levels of contamination associated with different procedures, drawn from Appendix 5 showing levels of contamination within studies to minimize dissimilarities in methodology, procedures and outcomes that might account for differences. Note that this must be interpreted with caution and will need to be modified as further evidence becomes available. *Indicates very low certainty.
Quality assessment of included studies (n = 83). Studies were ranked as low (red), moderate (amber) or high (green) for each parameter (see protocol for full description in Appendix 1). There is no summation across fields.